I. Lonjon

825 total citations
9 papers, 622 citations indexed

About

I. Lonjon is a scholar working on Epidemiology, Hepatology and Genetics. According to data from OpenAlex, I. Lonjon has authored 9 papers receiving a total of 622 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 6 papers in Hepatology and 2 papers in Genetics. Recurrent topics in I. Lonjon's work include Liver Disease Diagnosis and Treatment (6 papers), Hepatitis C virus research (5 papers) and Hepatitis B Virus Studies (4 papers). I. Lonjon is often cited by papers focused on Liver Disease Diagnosis and Treatment (6 papers), Hepatitis C virus research (5 papers) and Hepatitis B Virus Studies (4 papers). I. Lonjon collaborates with scholars based in France, United Kingdom and Israel. I. Lonjon's co-authors include Daniel Dhumeaux, Jean–Michel Pawlotsky, Christophe Hézode, Françoise Darthuy, Anne Bastie, Georgios Germanidis, Laurent Castéra, Harel Dahari, Avidan U. Neumann and Jocelyne Rémiré and has published in prestigious journals such as Gastroenterology, Hepatology and Journal of Hepatology.

In The Last Decade

I. Lonjon

9 papers receiving 599 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
I. Lonjon France	8	495	482	66	57	56	9	622
Michela Pasino Italy	8	437 0.9×	411 0.9×	109 1.7×	24 0.4×	97 1.7×	16	623
Junnosuke Watanabe Japan	7	304 0.6×	299 0.6×	68 1.0×	15 0.3×	25 0.4×	10	480
Subhash C. Gumber United States	6	186 0.4×	270 0.6×	19 0.3×	18 0.3×	48 0.9×	10	461
J.-P. Zarski France	8	586 1.2×	650 1.3×	35 0.5×	30 0.5×	9 0.2×	14	719
Piotr Stalke Poland	11	181 0.4×	145 0.3×	76 1.2×	30 0.5×	14 0.3×	42	335
Julia O’Brien United Kingdom	9	400 0.8×	399 0.8×	19 0.3×	74 1.3×	26 0.5×	12	510
Betty Jane S. Gerstley United States	9	264 0.5×	177 0.4×	38 0.6×	37 0.6×	13 0.2×	10	438
Angie Price United States	8	341 0.7×	394 0.8×	41 0.6×	69 1.2×	18 0.3×	13	498
V. Carreño Spain	19	864 1.7×	880 1.8×	35 0.5×	98 1.7×	10 0.2×	66	1.1k
Mary Ashcavai United States	16	550 1.1×	475 1.0×	25 0.4×	83 1.5×	34 0.6×	23	760

Countries citing papers authored by I. Lonjon

Since Specialization

Citations

This map shows the geographic impact of I. Lonjon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Lonjon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Lonjon more than expected).

Fields of papers citing papers by I. Lonjon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Lonjon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Lonjon. The network helps show where I. Lonjon may publish in the future.

Co-authorship network of co-authors of I. Lonjon

This figure shows the co-authorship network connecting the top 25 collaborators of I. Lonjon. A scholar is included among the top collaborators of I. Lonjon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Lonjon. I. Lonjon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Pawlotsky, Jean–Michel, Harel Dahari, Avidan U. Neumann, et al.. (2004). Antiviral action of ribavirin in chronic hepatitis C. Gastroenterology. 126(3). 703–714. 186 indexed citations

Hézode, Christophe, I. Lonjon, F Roudot-Thoraval, et al.. (2003). Impact of moderate alcohol consumption on histological activity and fibrosis in patients with chronic hepatitis C, and specific influence of steatosis: a prospective study. Alimentary Pharmacology & Therapeutics. 17(8). 1031–1037. 87 indexed citations

Pawlotsky, Jean–Michel, Anne Bastie, Christophe Hézode, et al.. (2000). Routine detection and quantification of hepatitis B virus DNA in clinical laboratories: performance of three commercial assays. Journal of Virological Methods. 85(1-2). 11–21. 68 indexed citations

Hézode, Christophe, Cécile Cazeneuve, I. Lonjon, et al.. (1999). Liver iron accumulation in patients with chronic active hepatitis C: prevalence and role of hemochromatosis gene mutations and relationship with hepatic histological lesions. Journal of Hepatology. 31(6). 979–984. 102 indexed citations

Pawlotsky, Jean–Michel, I. Lonjon, Christophe Hézode, et al.. (1998). What strategy should be used for diagnosis of hepatitis C virus infection in clinical laboratories?. Hepatology. 27(6). 1700–1702. 102 indexed citations

Hézode, Christophe, C. Cazeneuve, I. Lonjon, et al.. (1998). Liver iron overload in patients with chronic active hepatitis C. Prevalence, role of the hemochromatosis gene and relation with hepatic histological lesions. Journal of Hepatology. 28. 110–110. 2 indexed citations

Pawlotsky, Jean–Michel, Anne Bastie, I. Lonjon, et al.. (1997). What technique should be used for routine detection and quantification of HBV DNA in clinical samples?. Journal of Virological Methods. 65(2). 245–253. 43 indexed citations

Lonjon, I., Laurent Beaugerie, F. Carbonnel, et al.. (1996). [Prevalence and role of anticardiolipin antibodies in Crohn disease].. PubMed. 20(8-9). 633–7. 10 indexed citations

Poynard, Thierry, I. Lonjon, Philippe Mathurin, et al.. (1995). Prevalence of Cholelithiasis According to Alcoholic Liver Disease: A Possible Role of Apolipoproteins AI and AII. Alcoholism Clinical and Experimental Research. 19(1). 75–80. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact